GSA Capital Partners’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $515K | Buy |
+39,553
| New | +$515K | 0.04% | 903 |
|
|
2025
Q1 | – | Sell |
-29,476
| Closed | -$500K | – | 1632 |
|
|
2024
Q4 | $500K | Buy |
29,476
+20,059
| +213% | +$340K | 0.04% | 886 |
|
|
2024
Q3 | $219K | Sell |
9,417
-52,213
| -85% | -$1.21M | 0.02% | 1381 |
|
|
2024
Q2 | $1.5M | Buy |
+61,630
| New | +$1.5M | 0.1% | 275 |
|
|
2023
Q2 | – | Sell |
-28,827
| Closed | -$691K | – | 1498 |
|
|
2023
Q1 | $691K | Buy |
28,827
+18,546
| +180% | +$445K | 0.07% | 513 |
|
|
2022
Q4 | $174K | Buy |
+10,281
| New | +$174K | 0.02% | 1214 |
|
|
2022
Q3 | – | Sell |
-51,848
| Closed | -$816K | – | 1494 |
|
|
2022
Q2 | $816K | Buy |
+51,848
| New | +$816K | 0.12% | 220 |
|
|
2021
Q2 | – | Sell |
-5,311
| Closed | -$219K | – | 1304 |
|
|
2021
Q1 | $219K | Sell |
5,311
-1,200
| -18% | -$49.5K | 0.04% | 844 |
|
|
2020
Q4 | $282K | Buy |
+6,511
| New | +$282K | 0.05% | 774 |
|